1 completed, 1 recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Amyotrophic Lateral Sclerosis ALS: new trials by email Literature Review of Amyotrophic Lateral Sclerosis ALS trials Research Report on Amyotrophic Lateral Sclerosis ALS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intestinal Microbiome Transplant in ALS MTP-101C - Amyotrophic Lateral Sclerosis ALS | Phase 1 / Phase 2 | Recruiting | Duke University | 20 | 2026-01-27 | 2026-07-08 |
| ROAR-DIGAP: A Widely Inclusive, Largely Virtual Pilot Trial Utilizing DIGAP (Deep Integrated Genomics Analysis Platform) To Personalize Treatments Astaxanthin, Protandim, Melatonin - Amyotrophic Lateral Sclerosis ALS | Phase 2 | Completed | Duke University | 50 | 2024-06-12 | 2026-10-27 |
Amyotrophic Lateral Sclerosis (2)
Central Nervous System Diseases (2) · Metabolic Diseases (2) · Motor Neuron Disease (2) · Nervous System Diseases (2) · Neurodegenerative Diseases (2) · Neuromuscular Diseases (2) · Nutritional and Metabolic Diseases (2) · Proteostasis Deficiencies (2) · Spinal Cord Diseases (2) · TDP-43 Proteinopathies (2)
Melatonin (1) · Protandim (1) · astaxanthine (1) · mitoquinone (1)
Duke University (2)
United States (2)